SALZMAN GROUPThe Salzman Group (SG) is a privately-held GLP/GMP/GCP compliant global Contract Research Organization that offers an innovative, cross-functional, and integrated approach to drug development. Serving as both a boutique service organization, as well as an innovative biotech company, SG carries out comprehensive drug development including hit selection, drug design, process scale-up, formulation, pre-clinical efficacy modelling, and clinical studies through Phase III registration trials. Based on over two decades of drug development experience and a strong track record, SG continues to generate ground-breaking opportunities, as well as offer a unique and personalized service for the growing biotech industry.LET US TAKE YOU FROM HIT DEVELOPMENT TO DRUG REGISTRATIONOUR SERVICESWith over 100 employees, leading scientists, 3 international locations and state-of-the-art laboratories, our in-house expertise and professional network enable us to create inventive opportunities that tackle unmet medical needs, customized products and services and to overcome challenges throughout the drug development process.Learn all about our services at: http://www.salzmangrp.com/CONSULTANCY SERVICES• Drug Development Plan / Program Management• Regulatory Affairs• Intellectual Property Diligence, Development Strategy• Strategic Business ConsultingDRUG DEVELOPMENT SEVICES• Medicinal Chemistry• CMC / Scale up and Process Chemistry• Formulation Development• Analytical Methods• Cellular and Molecular Biology• Pharmacology• ADME/PK• Bioanalytics• Toxicology• QC and QA managementCLINICAL TRIAL MANAGEMENT• Clinical Trial Management• Pharmacovigilance• Data Management• BiostatisticsSalzman Group’s priority is to provide quality outcomes utilizing all these services or partial services as required to meet the needs of our clients.